Editorial
doi: 10.1056/NEJMe058038.
Epub 2005 Feb 15.
COX-2 inhibitors--a lesson in unexpected problems
- PMID: 15713947
- DOI: 10.1056/NEJMe058038
Item in Clipboard
Editorial
COX-2 inhibitors--a lesson in unexpected problems
N Engl J Med.
.
No abstract available
Comment in
-
Cardiovascular risk associated with celecoxib.N Engl J Med. 2005 Jun 23;352(25):2648-50; author reply 2648-50. doi: 10.1056/NEJM200506233522519. N Engl J Med. 2005. PMID: 15972876 No abstract available.
Comment on
-
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.N Engl J Med. 2005 Mar 17;352(11):1092-102. doi: 10.1056/NEJMoa050493. Epub 2005 Feb 15. N Engl J Med. 2005. PMID: 15713943 Clinical Trial.
-
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.N Engl J Med. 2005 Mar 17;352(11):1071-80. doi: 10.1056/NEJMoa050405. Epub 2005 Feb 15. N Engl J Med. 2005. PMID: 15713944 Clinical Trial.
-
Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.N Engl J Med. 2005 Mar 17;352(11):1081-91. doi: 10.1056/NEJMoa050330. Epub 2005 Feb 15. N Engl J Med. 2005. PMID: 15713945 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
